Questions for the Committee

36.            Members are invited to consider the following questions:

i)               Can the Committee identify a Point of Departure (PoD) on which the assessment of antimony should be based?

ii)             Is the Committee able to derive a health-based guidance value for antimony and if so, what uncertainty factors does the Committee propose to use with the NOAEL?

iii)            Are there any other uncertainties or considerations the Committee would like to highlight in evaluating antimony?

iv)           Does the Committee have any other comments?

Secretariat February 2025